XML 22 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Income (Loss) - EUR (€)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues € 44,912,000 € 39,183,000 € 35,746,000
Cost of sales (23,909,000) (22,266,000) (20,938,000)
Gross profit 21,002,000 16,917,000 14,808,000
Research and development expenses (3,728,000) (4,088,000) (3,881,000)
Selling and marketing expenses (10,850,000) (10,551,000) (9,526,000)
General and administrative expenses (4,224,000) (3,593,000) (3,428,000)
Income (loss) from operations 2,201,000 (1,315,000) (2,027,000)
Financial income (expense), net (146,000) 797,000 2,643,000
Foreign Currency exchange (losses) gains, net 136,000 538,000 (909,000)
Income (loss) before taxes 2,191,000 20,000 (293,000)
Income tax (expense) credit (679,000) (358,000) (388,000)
Net income (loss) € 1,512,056 € (338,382) € (681,345)
Basic income (loss) per share (in EUR per share) € 0.05 € (0.01) € (0.02)
Diluted income (loss) per share (in EUR per share) € 0.05 € (0.01) € (0.02)
Basic Weighted average shares outstanding (in shares) 29,016,118 28,997,866 28,961,928
Diluted Weighted average shares outstanding (in shares) 29,615,466 28,997,866 28,961,928
Product [Member]      
Revenues € 30,111,000 € 25,070,000 € 22,580,000
Cost of sales (15,442,000) (14,053,000) (13,170,000)
HIFU Treatments and Devices Leased [Member]      
Revenues 5,747,000 5,086,000 5,095,000
Cost of sales (3,000,000) (2,557,000) (2,667,000)
Parts and Services [Member]      
Revenues 9,001,000 9,007,000 8,011,000
Cost of sales (5,467,000) (5,655,000) (5,101,000)
Product and Services, Excluding Other [Member]      
Revenues 44,859,000 39,163,000 35,686,000
Product and Service, Other [Member]      
Revenues € 52,000 € 19,000 € 60,000